Akt Inhibitor MK2206 in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Clinical trial NCT01481129 · COMPLETED
Trial details
- NCT number
- NCT01481129
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2013-06-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.